{"id":"W2571353014","doi":"10.1016/j.ccell.2016.12.002","title":"Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma","year":2017,"lang":"en","type":"article","venue":"Cancer Cell","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":128,"is_retracted":false,"has_abstract":false,"ca_institutions":"Structural Genomics Consortium; University of Toronto","funders":"National Institute of General Medical Sciences; National Institutes of Health; Fundação de Amparo à Pesquisa do Estado de São Paulo; Ontario Genomics Institute; Canada Foundation for Innovation; Ontario Ministry of Economic Development and Innovation; Wellcome Trust; Eshelman Institute for Innovation, University of North Carolina at Chapel Hill; St. Baldrick's Foundation; Ministero dell’Istruzione, dell’Università e della Ricerca; AbbVie; Janssen Biotech; Innovative Medicines Initiative; Associazione Italiana per la Ricerca sul Cancro; Wellcome; Merck; Takeda Pharmaceuticals U.S.A.; Pfizer; Boehringer Ingelheim","keywords":"Epigenetics; Druggability; Chromatin; Biology; Small interfering RNA; Cancer research; Methyltransferase; Genetics; Bioinformatics; Cell biology; RNA; Gene; Methylation","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001919573,0.0003233696,0.0003332295,0.0003065957,0.000234289,0.0003515147,0.0003352702,0.0004077849,0.003562337],"category_scores_gemma":[0.0001683435,0.0001620367,0.000365874,0.0001523054,0.0002143285,0.0001809434,0.0002247583,0.0006615805,0.0004778639],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004169102,"about_ca_system_score_gemma":0.0002817825,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006106409,"about_ca_topic_score_gemma":0.002664015,"domain_scores_codex":[0.9998521,0.00001780297,0.00001416586,0.00002726684,0.00006029203,0.0000283152],"domain_scores_gemma":[0.9999425,0.000015476,0.00001225047,0.00000858066,0.0000101854,0.00001099066],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0002749526,0.0001215605,0.0005473386,0.00008576951,0.00003048826,0.0001264055,0.00001514469,0.0004005805,0.9874601,0.0005010304,0.0005208615,0.009915707],"study_design_scores_gemma":[0.00006111798,0.0004823533,0.002408166,0.000007565724,0.00005736205,0.0003550484,0.00002917248,0.001271936,0.9900619,0.0001183565,0.005139837,0.000007211461],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9748724,0.003205233,0.007923932,0.0006477537,0.0001906553,0.0001484471,0.001519908,0.00037328,0.01111834],"genre_scores_gemma":[0.9892558,0.001477753,0.003619789,0.0001773371,0.00001199993,0.00007907172,0.0007646249,0.00003379146,0.004579756],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003562337,"threshold_uncertainty_score":0.01191717,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03744754336170057,"score_gpt":0.3529582167922486,"score_spread":0.3155106734305481,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}